Looking beyond Covid-19, the two Simons and Tim talk to Paul about the issues facing pharmaceutical companies, why GlaxoSmithKline is coming under pressure and one of the largest biopharma companies you may have never heard of…
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
